Medicare Enrolled
Dr. Soon Jung, MD
Pain Medicine · Allentown, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jung from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jung?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jung
Dr. Soon Jung is a pain medicine specialist in Allentown, PA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Jung performed 13,061 Medicare services across 2,198 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jung received a total of $76,058 from 57 pharmaceutical and/or device companies across 796 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jung is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 1% volume in PA
$76,058 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,061
Medicare services
Top 1% in PA for pain medicine
2,198
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,005 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bupivacaine injection, 0.5 mg An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg. |
5,850 | $0 | $4 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
2,364 | $1 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,301 | $103 | $652 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
1,171 | $4 | $27 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
345 | $53 | $205 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
303 | $61 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
254 | $75 | $459 |
| Contrast dye for imaging, lower concentration | 210 | $0 | $3 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
168 | $133 | $844 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
134 | $153 | $780 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
105 | $100 | $605 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
101 | $111 | $575 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
95 | $277 | $2,092 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
88 | $220 | $1,407 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
80 | $61 | $395 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
71 | $242 | $1,000 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
55 | $9 | $189 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
48 | $796 | $5,750 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
48 | $74 | $461 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
39 | $150 | $1,043 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
38 | $50 | $316 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
36 | $96 | $583 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
35 | $40 | $199 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
33 | $221 | $1,425 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
28 | $190 | $1,497 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
28 | $100 | $749 |
| Hip injection of contrast under anesthesia A contrast dye is injected into the hip joint while the patient is under anesthesia to facilitate medical imaging. |
20 | $299 | $2,036 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $95 | $563 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$76,058
Total received (2018-2024)
Avg $10,865/year across 7 years
Top 2% in PA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
796
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$49,226 (64.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,940 (23.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,892 (11.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,217
2023
$6,361
2022
$10,743
2021
$15,928
2020
$4,448
2019
$16,563
2018
$19,799
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$560
Boston Scientific Corporation
$366
PAINTEQ LLC
$271
Collegium Pharmaceutical, Inc.
$242
Stryker Corporation
$184
Nevro Corp.
$127
IBSA Pharma Inc.
$124
ABBVIE INC.
$74
Vertos Medical, Inc.
$48
Valinor Pharma, LLC
$42
SI-BONE, INC.
$32
Neurocrine Biosciences, Inc.
$31
VERTEX PHARMACEUTICALS INCORPORATED
$29
Teva Pharmaceuticals USA, Inc.
$20
Lilly USA, LLC
$18
Pacira Pharmaceuticals Incorporated
$18
Azurity Pharmaceuticals, Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 54.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$27,371
Medtronic USA, Inc.
$18,089
BOSTON SCIENTIFIC CORPORATION
$15,256
Abbott Laboratories
$4,238
Vertiflex, Inc.
$2,052
Nevro Corp.
$1,415
Medtronic, Inc.
$1,095
Vertos Medical, Inc.
$905
Collegium Pharmaceutical, Inc.
$877
ABBVIE INC.
$529
PFIZER INC.
$331
Relievant Medsystems, Inc.
$321
PAINTEQ LLC
$307
Stryker Corporation
$259
Nalu Medical, Inc.
$238
Nuvectra Corporation
$230
IBSA Pharma Inc.
$220
Flowonix Medical Incorporated
$204
Scilex Pharmaceuticals Inc.
$193
Lilly USA, LLC
$182
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$172
Foundation Fusion Solutions, LLC
$133
TerSera Therapeutics LLC
$96
Neuronetics, Inc.
$80
Stimwave Technologies Incorporated
$75
Kowa Pharmaceuticals America, Inc.
$69
FORTE BIO-PHARMA LLC
$69
Teva Pharmaceuticals USA, Inc.
$67
Valinor Pharma, LLC
$61
Averitas Pharma Inc.
$59
Forte Bio-Pharma LLC
$59
SCILEX PHARMACEUTICALS INC.
$58
Fidia Pharma USA Inc.
$57
Kaleo, Inc.
$54
Amneal Pharmaceuticals LLC
$50
AstraZeneca Pharmaceuticals LP
$49
Daiichi Sankyo Inc.
$47
Pernix Therapeutics Holdings, Inc.
$38
Curonix LLC
$38
MML US, Inc.
$37
Assertio Therapeutics, Inc.
$36
Axsome Therapeutics, Inc.
$32
SI-BONE, INC.
$32
Neurocrine Biosciences, Inc.
$31
GRT US Holding, Inc.
$31
VERTEX PHARMACEUTICALS INCORPORATED
$29
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$28
AbbVie Inc.
$26
Radius Health, Inc.
$21
Pacira Pharmaceuticals Incorporated
$18
Currax Pharmaceuticals LLC
$17
Amgen Inc.
$16
Azurity Pharmaceuticals, Inc.
$16
Trevena, Inc.
$13
Horizon Therapeutics plc
$13
Purdue Pharma L.P.
$12
Electronic Waveform Lab, Inc.
$10
Top 3 companies account for 79.8% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AUSTEDO · AVISTA · Aimovig · Algovita · Austedo XR · Axium INS DRG IPG · BELBUCA · Belbuca · CASCADIA INTERBODY SYSTEM · CONTRAVE · DRG IPGs · ELEVATE · ELYXYB - celecoxib · EMGALITY · ETERNA · EXCLAIM · Evzio · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · General - Pain Management · General - Therapies · Gralise · HORIZANT · HYALGAN · HYMOVIS · INFINION · INGREZZA · INTELLIS · Infinion 16 · Intracept · Iovera · KYPHON Balloon Kyphoplasty · LAMITRODE · LICART · LIORESAL · LYRICA · LYVISPAH · Lamitrode SCS Leads · MILD DEVICE KIT · MOVANTIK · Morphabond ER · NALOCET · NEUROSTAR TMS THERAPY · Nalu Neurostimulation System · OCTRODE · OSTEOCOOL RF ABLATION · OXYCONTIN · Octrode SCS Leads · Olinvyk · Omnia · PAINTEQ · PAXLOVID · PENNSAID · PENTA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · PROLATE · Penta SCS Leads · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Proclaim XR IPG · Prometra II · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · ReActiv8 · SEGLENTIS · SERRATO · SPECTRA WAVEWRITER · SUPERION · SYNCHROMED · Seglentis · Senza · StimQ Receiver Stimulator Kit Channel A US w Receiver · Sunosi · Superion · Superion ISS · TRILURON · Tirosint · Tymlos · UBRELVY · UNiD · VECTRIS · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZIPSOR · ZOHYDRO ER · ZTLido · Zipsor · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (65%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pain medicine in PA.
Geographic Context
Pain medicines within 10 mi
23
Per 100K population
6.1
County median income
$77,493
Nearest hospital
LEHIGH VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jung is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with speaking/promotional industry engagement in the top 2% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jung experienced with bupivacaine injection, 0.5 mg?
Based on Medicare claims data, Dr. Jung performed 5,850 bupivacaine injection, 0.5 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jung receive payments from pharmaceutical companies?
Yes. Dr. Jung received a total of $76,058 from 57 companies across 796 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jung's costs compare to other pain medicines in Allentown?
Dr. Jung's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jung) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Allentown
Browse pain medicines in Allentown ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in PA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in PA
Which PA pain medicines receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology